[Controlled clinical study of the use of creatinol-O-phosphate in subjects with deficient myocardial circulation].
D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy*; D003401:Creatine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D010919:Placebos
D010919:Placebos; C100173:creatinol phosphate; D003401:Creatine
Studio clinico controllato sull'uso del creatinolo-o-fosfato in soggetti con deficit di irrorazione miocardica.